News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Kumar Ramesh
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/09/2023 |
4
| Kumar Ramesh (Director) has filed a Form 4 on Ocugen, Inc.|
Txns:
| Granted 112,205 options to buy
@ $0.4581, valued at
$51.4k
|
|
| 10/07/2022 |
4
| Kumar Ramesh (Director) has filed a Form 4 on Ocugen, Inc.|
Txns:
| Sold 4,500 shares
@ $1.83, valued at
$8.2k
Exercised 4,500 options to buy
@ $0.51, valued at
$2.3k
|
|
| 07/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/20/2022 |
4
| Kumar Ramesh (Director) has filed a Form 4 on Ocugen, Inc.|
Txns:
| Sold 7,500 shares
@ $2.83, valued at
$21.2k
Exercised 7,500 options to buy
@ $0.51, valued at
$3.8k
|
|
| 01/20/2022 |
4
| Kumar Ramesh (Director) has filed a Form 4 on Ocugen, Inc.|
Txns:
| Sold 7,500 shares
@ $4.07, valued at
$30.5k
Exercised 7,500 options to buy
@ $0.51, valued at
$3.8k
|
|
| 12/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/20/2021 |
4
| Kumar Ramesh (Director) has filed a Form 4 on Ocugen, Inc.|
Txns:
| Sold 7,500 shares
@ $8.13, valued at
$61k
Exercised 7,500 options to buy
@ $0.51, valued at
$3.8k
|
|
| 07/21/2021 |
4
| Kumar Ramesh (Director) has filed a Form 4 on Ocugen, Inc.|
Txns:
| Sold 7,500 shares
@ $6.4, valued at
$48k
Exercised 7,500 options to buy
@ $0.51, valued at
$3.8k
|
|
| 04/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/16/2019 |
3
| Kumar Ramesh (Director) has filed a Form 3 on Ocugen, Inc. |
| 07/30/2018 |
4
| Kumar Ramesh (CEO) has filed a Form 4 on Onconova Therapeutics, Inc.|
Txns:
| Granted 1,065,600 options to buy
@ $0.46, valued at
$490.2k
|
|
| 02/27/2018 |
4
| Kumar Ramesh (President and CEO) has filed a Form 4 on Onconova Therapeutics, Inc.|
Txns:
| Granted 73,220 options to buy
@ $1.09, valued at
$79.8k
|
|
| 01/05/2018 |
4
| Kumar Ramesh (President and CEO) has filed a Form 4 on Onconova Therapeutics, Inc.|
Txns:
| Granted 64,885 options to buy
@ $1.5, valued at
$97.3k
|
|
| 04/28/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/19/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/19/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/01/2016 |
4
| Kumar Ramesh (President and CEO) has filed a Form 4 on Onconova Therapeutics, Inc.|
Txns:
| Granted 44,000 options to buy
@ $3.24, valued at
$142.6k
|
|
| 08/10/2016 |
4
| Kumar Ramesh (President and CEO) has filed a Form 4 on Onconova Therapeutics, Inc.|
Txns:
| Exercised (in-or-at-the-money) 50,765 shares
@ $4.1, valued at
$208.1k
Exercised (in-or-at-the-money) 41,475 rights
@ $4.1, valued at
$170k
Exercised (in-or-at-the-money) 38,071 warrants
@ $4.92, valued at
$187.3k
|
|
| 01/28/2016 |
4
| Kumar Ramesh (President and CEO) has filed a Form 4 on Onconova Therapeutics, Inc.|
Txns:
| Granted 146,440 options to buy
@ $0.65, valued at
$95.2k
|
|
| 10/01/2015 |
4
| Kumar Ramesh (President and CEO) has filed a Form 4 on Onconova Therapeutics, Inc.|
Txns:
| Granted 87,500 options to buy
@ $1.48, valued at
$129.5k
|
|
| 04/20/2015 |
4
| Kumar Ramesh (President and CEO) has filed a Form 4 on Onconova Therapeutics, Inc.|
Txns:
| Granted 87,500 options to buy
@ $2.32, valued at
$203k
|
|
| 12/22/2014 |
4
| Kumar Ramesh (President and CEO) has filed a Form 4 on Onconova Therapeutics, Inc.|
Txns:
| Granted 175,000 options to buy
@ $3.98, valued at
$696.5k
|
|
| 02/11/2014 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/03/2014 |
4
| Kumar Ramesh (President and CEO) has filed a Form 4 on Onconova Therapeutics, Inc.|
Txns:
| Sold 20,000 shares
@ $15.05, valued at
$301k
Sold 20,000 shares
@ $15.03, valued at
$300.6k
Sold 20,000 shares
@ $15.07, valued at
$301.4k
Exercised 5,256 options to buy
@ $2.67, valued at
$14k
Exercised 14,744 options to buy
@ $6, valued at
$88.5k
Exercised 20,000 options to buy
@ $6, valued at
$120k
Exercised 20,000 options to buy
@ $6, valued at
$120k
|
|
| 12/24/2013 |
4
| Kumar Ramesh (President and CEO) has filed a Form 4 on Onconova Therapeutics, Inc.|
Txns:
| Granted 135,000 options to buy
@ $13.48, valued at
$1.8M
|
|
| 11/18/2013 |
4
| Kumar Ramesh (President and CEO) has filed a Form 4 on Onconova Therapeutics, Inc.|
Txns:
| Bought 1,100 shares
@ $12.02, valued at
$13.2k
|
|
| 08/01/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 07/29/2013 |
4
| Kumar Ramesh (President and CEO) has filed a Form 4 on Onconova Therapeutics, Inc.|
Txns:
| Granted 5,000 options to buy
@ $15, valued at
$75k
Granted 100,000 options to buy
@ $15, valued at
$1.5M
|
|
|
|